EUVIMEDEUVIMED entdecken
Open Access

Adult U.S. Poison Center Exposure Case Trends Involving Nonprescription Dextromethorphan Amid the COVID-19 Pandemic: a Quasi-experimental Interrupted Time Series Study

Sara Karami, Christian Angelo I Ventura, Ellen Pinnow, Nana Dwumfour, Ajoa Asonye, Gerald Dal Pan, Esther H Zhou

Journal of Medical Toxicology · 2026

DOI: 10.1007/s13181-026-01159-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Toxicology, 2026. Verfasst von Sara Karami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Silver Spring, MD, …. Hauptthemen laut MEDLINE: Dextromethorphan, Poison Control Centers, Nonprescription Drugs, Antitussive Agents. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Nonprescription dextromethorphan (DXM) is widely available in the United States and was commonly recommended for managing dry cough associated with COVID-19. This retrospective study of Poison Center data evaluated whether the COVID-19 pandemic impacted monthly adult exposure case trends involving nonprescription DXM cold and cough preparations. METHODS: We performed interrupted time series analyses using a pre-pandemic baseline period of January 2015-February 2020, and pandemic period of April 2020-April 2023. The pandemic's immediate impact (level change, March 2020) and sustained trend effects were modeled separately by exposure reason categories. RESULTS: Monthly nonprescription DXM exposure cases declined immediately at the pandemic's onset, and remained low for approximately one year across all age and sex subgroups. Unintentional-therapeutic error exposures subsequently rebounded for some subgroups, particularly females (+ 3 cases/month; 95% CI: 2.7-3.4; p < 0.0001), surpassing pre-pandemic levels by the study's end. Intentional-abuse/misuse exposures had been dramatically declining pre-pandemic; significant trend increase changes were observed among males (+ 0.8 cases/month; 95% CI: 0.5-1.1; p < 0.0001) and adults aged 18-29 years (+ 0.9 cases/month; 95% CI: 0.7-1.1; p < 0.0001) during the pandemic, though the absolute magnitude of these changes was small and warrant cautious interpretation. CONCLUSIONS: Nonprescription DXM exposures declined sharply at the pandemic's onset, with unintentional-therapeutic errors subsequently rebounding - especially among females - surpassing pre-pandemic levels toward the end of the pandemic's public health emergency declaration, while intentional exposures showed modest changes following initial declines. These findings underscore the need for targeted prevention strategies regarding inappropriate nonprescription DXM use and enhanced medication safety messaging during prolonged public health crises.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DextromethorphanPoison Control CentersNonprescription DrugsAntitussive AgentsCOVID-19HumansMaleUnited StatesRetrospective StudiesFemaleAdultInterrupted Time Series AnalysisMiddle AgedYoung Adult

Stichwörter der Autor:innen

COVID-19Dextromethorphan; nonprescription exposuresPoison CentersTherapeutic error

Substanzen

DextromethorphanNonprescription DrugsAntitussive Agents

Autor:innen und Institutionen

  • Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Silver Spring, MD, USA. Sara.Karami@fda.hhs.gov.
  • Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), 10903 New Hampshire Avenue, Building 22, Silver Spring, MD, USA.

Zitieren

APA

Karami, S., Ventura, C. A. I., Pinnow, E., Dwumfour, N., Asonye, A., Pan, G. D., & Zhou, E. H. (2026). Adult U.S. Poison Center Exposure Case Trends Involving Nonprescription Dextromethorphan Amid the COVID-19 Pandemic: a Quasi-experimental Interrupted Time Series Study. Journal of Medical Toxicology. https://doi.org/10.1007/s13181-026-01159-z

Vancouver

Karami S, Ventura CAI, Pinnow E, Dwumfour N, Asonye A, Pan GD, et al. Adult U.S. Poison Center Exposure Case Trends Involving Nonprescription Dextromethorphan Amid the COVID-19 Pandemic: a Quasi-experimental Interrupted Time Series Study. Journal of Medical Toxicology. 2026. doi:10.1007/s13181-026-01159-z

BibTeX
@article{Karami2026,
  author = {Karami, Sara and Ventura, Christian Angelo I and Pinnow, Ellen and Dwumfour, Nana and Asonye, Ajoa and Pan, Gerald Dal and Zhou, Esther H},
  title = {Adult U.S. Poison Center Exposure Case Trends Involving Nonprescription Dextromethorphan Amid the COVID-19 Pandemic: a Quasi-experimental Interrupted Time Series Study},
  journal = {Journal of Medical Toxicology},
  year = {2026},
  doi = {10.1007/s13181-026-01159-z}
}
Kostenlos starten →